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Daqiao Guo, MD,a Xin Xu, MD,a and Bin Chen, MD,a Shanghai, China
Background: Stent graft-induced new entry (SINE), defined as the new tear caused by the stent graft and excluding those
arising from natural disease progression or iatrogenic injury from the endovascular manipulation, has been increasingly
observed after thoracic endovascular aortic repair (TEVAR) for Stanford type B dissection in our center. SINE appears
to be remarkably life threatening.We investigated the incidence, mortality, causes, and preventions of SINE after TEVAR
for Stanford type B dissection.
Methods: Data for 22 patients with SINE were retrospectively collected and analyzed from 650 patients undergoing
TEVAR for type B dissection from August 2000 to June 2008. An additional patient was referred to our center 14
months after TEVAR was performed in another hospital. The potential associations of SINE with Marfan syndrome,
location of SINE and endograft placement, and the oversizing rate were analyzed by Fisher exact probability test or t test.
Results:We found 24 SINE tears in 23 patients, including SINE at the proximal end of the endograft in 15, at the distal
end in 7, and at both ends in 1. Six patients died. SINE incidence and mortality reached 3.4% and 26.1%, respectively.
Two SINE patients were diagnosed with Marfan syndrome, whereas there were only 6 Marfan patients among the 651
patients. The 16 proximal SINEs were evidenced at the greater curve of the arch and caused retrograde type A dissection.
The eight distal SINEs occurred at the dissected flap, and five caused enlarging aneurysm whereas three remained stable.
The endograft was placed across the distal aortic arch during the primary TEVAR in all 23 patients. The incidence of
SINE was 33.33% among Marfan patients vs 3.26% among non-Marfan patients (P  .016). There was no significant
difference in mortality between proximal and distal SINE (25% vs 28.6%, P> .99), incidence of SINE between endograft
placement across the arch and at the straight portion of descending thoracic aorta (23 of 613 vs 0 of 38, P  .39), and
the oversizing rate between SINE and non-SINE patients (13%  4.5% vs 16%  6.5%, P  .98).
Conclusions: SINE appears not to be rare after TEVAR for type B dissection and is associated with substantial mortality. The
stress yielded by the endograft seems to play a predominant role in its occurrence. It is important to take this stress-induced
injury into account during both design and placement of the endograft. (J Vasc Surg 2010;52:1450-8.)Thoracic endovascular aortic repair (TEVAR) has been
increasingly used in the treatment of Stanford type B dis-
section after its safety and efficacy were reported at the end
of the last century.1,2 Currently, the annual volume of
TEVAR in many hospitals outnumbers that of graft re-
placement, and TEVAR has gradually become the main-
stream procedure for complicated type B dissection. On the
other hand, the long-term durability of this minimally
invasive procedure has continuously remained a source of
concern, and whether the stiff stent graft itself would bring
about any potential injury on the aorta represents a main
concern.
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1450From August 2000 to June 2008, 650 patients under-
went TEVAR for type B dissection in our center. Among
them, a stent graft-induced new entry (SINE) tear devel-
oped perioperatively or during the follow-up in 22 patients,
with 6 deaths. SINEwas defined as a new tear caused by the
stent graft itself, excluding those created by natural disease
progression or any iatrogenic injury from the endovascular
manipulation. Proximal and distal SINE represented the
SINE at the proximal and distal end of the endograft,
respectively. Its incidence and mortality reached 3.4% and
26.1%, respectively.
We initiated this study because to date, systematic
investigation of this infrequent but high-mortality compli-
cation has been lacking. The limited information can only
be obtained from solitary case reports3 or extracted from
studies about the general outcomes of TEVAR4-22 or post-
TEVAR retrograde type A dissection (RTAD).23-25
METHODS
Data collection and analysis. All-cause new entries
after TEVAR were retrospectively collected among 650
patients undergoing TEVAR for type B dissection in our
center from August 2000 to June 2008. The data of
patients complicated with SINEwere extracted for analysis.
The proportion of SINE among all-cause new entries and
among all TEVAR- or dissection-related deaths was calcu-
lated. MEDLINE was searched with the term “aortic dis-
tion o
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and the proportion of SINE among them.
Stent graft systems. Four stent graft systems were
used in this series: Talent and Valiant (Medtronic, Minne-
apolis, Minn), Hercules (Microport, Shanghai, China), and
Zenith TX2 (Cook, Bjaeverskov, Denmark). These self-
expanding endografts have an inherent tendency to spring
back to their initial straight status if passively bent, such as
when placed across the aortic arch (Fig 1). Talent, Valiant,
and Hercules have a proximal bare spring. Talent and
Hercules have a longitudinal connecting bar that prevents
twisting and kinking but sacrifices flexibility. Oversizing
was calculated according to the diameter from the adven-
titia to adventitia of the proximal landing zone on com-
puted tomography angiography (CTA).
Endovascular stent graft placement. The general
procedure of TEVAR has been detailed elsewhere.25,26 If
the proximal landing zone, the distance from the origin of
the left subclavian artery to the primary entry site, measured
15 mm, one of the two strategies would be applied to
create an extra anchoring area:
1. Intentional coverage of the left subclavian artery, if it
was proven beforehand that the right vertebral artery
was patent and the left one was not dominant;
2. Right-to-left carotid plus left carotid-to-left subclavian
arterial bypass and proximal ligation of the left carotid
and subclavian arteries.
Both strategies have been described in detail.27 A comple-
tion angiogram was performed at the end of the TEVAR to
confirm the accurate endograft fixation at the anticipated
Fig 1. A,When passively bent at the arch, the self-expand
back to its initial straight status, especially in the presence of
could yield stress on the greater curve, particularly at tw
angiography (CTA) at 28months detected an asymptomat
29 months showed a proximal SINE (long arrow) and res
arrow) remained stable. D, At 12 months after the graft re
distal SINEexpanded (arrow).EandF,By27months after
to contained rupture.G andH, At 3 months after an urgen
complete seal of the distal SINE (arrow) and entire absorplocation and satisfactory exclusion of the primary entry site.Treatment of SINE. For proximal SINE that unex-
ceptionally caused RTAD, graft replacement of the ascend-
ing thoracic aorta with or without partial or total aortic arch
replacement was the first choice upon its onset. Medical
management was chosen only if RTAD was limited and the
patient remained clinically stable.
For distal SINE, medical treatment was preferred upon
the diagnosis. The indication for reintervention included
persistent enlargement of the false lumen, contained rup-
ture, and becoming symptomatic. Secondary TEVAR was
preferred for reintervention. Surgical graft replacement of
the descending thoracic aorta was used if a large dissecting
aneurysm was causing notable compression that would not
be relieved simply by TEVAR. If the reintervention in-
volved the distal descending thoracic aorta, the Adamk-
iewicz artery would be preoperatively located by CTA, and
cerebrospinal fluid (CSF) pressure would be monitored
intraoperatively and postoperatively, with CSF drainage if
necessary.
Medical management included -blockers, angio-
tensin-converting enzyme inhibitors, angiotensin recep-
tor blockers, or calcium antagonists administrated alone
or in combination to maintain the systolic blood pressure
140 mm Hg.
Follow-up protocol. Patients were followed-up by
CTA at 1, 3, and 6 months, and yearly thereafter after the
primary TEVAR and after the secondary procedure for
SINE. For patients with SINE treated by medicine, CTA
was performed at least every 3 to 6 months.
Statistical analysis. The Fisher exact probability test
was used to evaluate significant differences in incidence
ent graft, like a spring, has the inherent tendency to spring
ngitudinal connecting bar (red). Such spring-back strength
ds of the graft. B, In patient 3, computed tomography
al stent graft-induced new entry (SINE; arrow).C,CTA at
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distal SINE, and the incidence of SINE between en-
dograft placement across the arch and at the straight
portion of descending thoracic aorta. The t test was used
to analyze the difference in the oversizing rate between
SINE and non-SINE patients. A value of P .05 was
considered significant. The analysis was completed with
STATA 8.0 software (StataCorp, College Station, Tex).
RESULTS
Data for 27 dissection cases complicated with all-cause
post-TEVAR new SINE tears have been collected in our
center. Among them, 2 (7.4%) were caused by disease
progression and diagnosed by follow-up CTA demonstrat-
ing the new entry at the proximal ascending thoracic aorta
irrelevant to the endograft, 2 (7.4%) resulted from endo-
vascular iatrogenic injury and were revealed by the intraop-
erative angiogram at the conclusion of the primary TEVAR
(one was due to pushing a partially released delivery system
forward at the arch, the other was ascribed to the cutting
injury by the radiopaque gold markers of the angiographic
catheter) and detailed previously,25 and 23 (85.2%) were
attributed to SINE and diagnosed according to the follow-
ing criteria: (1) CTA or echocardiography showed the new
entry located at either end of the endograft, (2) no new
Table. Characteristics of 23 patients complicated with ste
aortic repair (TEVAR) for type B dissection
Patient
Age
(year)
Coexisting
conditions Onset time
SINE
symptoms D
1 53 Hypertension 1 mo Hypertension,
syncope
T
2 43 Hypertension 6 mo Chest pain T
3 41 Hypertension 28 & 29 mo Asymptomatic
chest pain,
fever
T
4 34 Hypertension 12 mo Hypoxia T
5 52 Hypertension 9 mo Chest pain T
6 32 Marfan 1 mo Chest pain T
7 39 Hypertension 36 mo Hypoxia T
8 53 Hypertension 1 wk Dyspnea T
9 47 Marfan 2 h Sudden death T
10 63 Hypertension 3 mo Chest pain V
11 50 Hypertension 60 mo Asymptomatic T
12 59 None 1 mo Dyspnea V
13 50 Hypertension 1 wk Chest pain,
dyspnea
V
14 37 Hypertension 3 h Dyspnea H
15 57 Hypertension 3 h Sudden death V
16 35 Hypertension 3 wk Sudden death V
17 59 Hypertension 3 mo Asymptomatic Z
18 45 Hypertension 3 mo Asymptomatic Z
19 71 Hypertension 15 mo Asymptomatic T
20 64 Hypertension 12 mo Asymptomatic V
21 53 Hypertension 33 mo Asymptomatic T
22 67 Hypertension 3 mo Chest pain,
fever
V
23 58 Hypertension 14 mo Chest pain Ventry was detected by the completion angiogram at the endof the primary TEVAR, and (3) during the surgical conver-
sion for RTAD, the proximal bare spring of the stent graft
was seen protruding into the false lumen through the new
entry.
Among the 23 SINE cases (18 men, 5 women; mean
age, 51  11 years, range, 32 to 71), 22 (17 men, 5
women) underwent the primary TEVAR at our center,
accounting for 3.4% among 650 patients, and an additional
patient (patient 23) was referred to our center 14 months
after TEVAR in another hospital. Of these 23 patients, 19
underwent primary TEVAR during the subacute phase for
recurrent chest pain in 6, refractory hypotension in 4,
40-mm-diameter patent false lumen in 5,28 malperfusion
in 3, and contained rupture in 1. The remaining four
patients (patients 8, 12, 22, 23) were in the chronic phase,
with10 years of history for55-mm-diameter dissecting
aneurysm. Their clinical characteristics are reported in the
Table.
The oversizing rate was 13% 4.5% (range, 3%-20%)
in SINE patients and 16%  6.5% (range, 3%-25%) in
non-SINE patients, which was not significantly different
(P  .98). Two of the 23 patients were diagnosed with
Marfan syndrome according to the revised Gent crite-
ria,29 whereas there were only 6 Marfan cases among all
651 patients, of whom 4 had solitary type B dissection
aft-induced new entry (SINE) after thoracic endovascular
, oversizing SINE location Treatment
Follow-up
duration
, 10% Proximal Surgery 43 mo
, 15% Proximal Surgery 80 mo
, 10% Distal proximal TEVAR
(56 mo)
Surgery
65 mo
, 15% Proximal Surgery 56 mo
, 10% Proximal Surgery 30 mo
, 10% Proximal Medical 21 d (lost)
, 10% Proximal Surgery 63 mo
, 10% Proximal Surgery 8 d (died)
, 10% Proximal Sudden death 2 h (died)
, 22% Proximal Medical 27 mo
, 15% Proximal Surgery 75 mo
, 13% Proximal Surgery 19 mo
, 3% Proximal Surgery 17 mo
es, 12% Proximal Surgery 9 mo
, 10% Proximal Sudden death 3 h (died)
, 15% Proximal Sudden death 3 wk (died)
TX2, 10% Distal Medical 17 mo
TX2, 20% Distal Medical 16 mo
, 18% Distal and suspected
proximal
TEVAR 16 mo (died)
, 15% Distal Medical 40 mo
, 15% Distal TEVAR 36 mo
, 20% Distal Surgery 10 mo (died)
, 20% Distal TEVAR 17 mont gr
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Marfan patients was 33.33% (2 of 6), which was signifi-
cantly higher than the 3.26% among non-Marfan pa-
tients (21 of 645; P  .016).
Our center documented 12 procedure-related or
dissection-related deaths after TEVAR for type B dissec-
tion. Among them, 6 (50%) were complicated with the
new entry, 3 (25%) with stroke, 1(8.3%) with endoten-
sion, 1 (8.3%) with rupture, and 1 (8.3%) with stent graft
failure to fully open, indicating that the post-TEVAR
new entry made up the largest proportion.
A MEDLINE search collected 70 post-TEVAR new en-
try cases from27 articles published between January 2002 and
January 2009.3-22,24,30-35 Among them, new entries were
proximal to the endograft in 64 patients,4-21,24,30-35 andwere
at the distal end of the stent graft in 6.3,18,20,22 The primary
TEVAR was for aortic dissection in 64 patients3-22,24,30-34
and for descending thoracic aneurysm in 6.13,17,21,24,35 SINE
caused 28 cases (40%),4-5,7-8,12-15,18,20,22,24,31-34 natural dis-
ease progression caused 7,10,11,13,15,18 and endovascular ma-
nipulation-related injury caused 11 (15.7%), including 3 by
guidewire6,30,35 and 8 by ballooning.9,17,18,24 The cause in
the remaining 24 (34.3%) was not indicated.We thus inferred
that SINE caused the largest proportion among all-cause
post-TEVAR new entry tears, consistent with the data from
our center.
The post-TEVAR onset of SINE was a mean of 11 
16 months (range, 2 hours-60 months). Proximal SINE
developed in 15 patients, distal developed in 7, and 1 had
both (patient 3). We hence collected 24 SINE tears in 23
patients, 16 proximal and 8 distal. The clinical manifesta-
tions included chest pain, hypoxia, dyspnea, syncope, fever,
and sudden death. One proximal and six distal SINEs were
asymptomatic when detected by follow-up CTA. All 16
proximal SINEs resulted in RTAD. Of these, 11 were
treated with surgical conversion, which resulted in 1 post-
operative death of multiple organ failure; 2 were treated
medically, and 3 died suddenly of pericardial tamponade.
Among 8 distal SINEs, 3 patients were given medical
treatment because the false lumen remained stable, patients
3, 19, 21, 23 underwent a secondary TEVAR, and patient
22 received surgical conversion.
Distal SINE was incidentally detected in patient 19 by
CTA at 15 months and was successfully excluded by place-
ment of a Hercules endograft (36  34  160 mm). We
were told during a follow-up telephone call 1 month later
that he had died suddenly at home 2 days earlier. Despite
the absence of an autopsy, we suspected that the proximal
SINE and resultant RTAD could have developed subse-
quent to the secondary TEVAR, which might transfer the
stress concentration from the distal to the proximal end of
the endograft (Fig 2).
Patient 22 presented with chest pain and fever 3
months after the primary TEVAR for an 80-mm-diame-
ter dissecting aneurysm, and CTA demonstrated the
distal SINE. The patient refused immediate reinterven-
tion. Six months later, the aneurysm had expanded up to
104 mm and significantly compressed the left lung. Graftreplacement of descending thoracic aorta was per-
formed; however, the patient died of multiple organ
failure on postoperative day 2. So, there were six deaths
in the present series, and the overall mortality reached
26.1%. Mortality was 25% (4 of 16) in proximal and
28.6% (2 of 7) in distal SINE, which was not significantly
different (P  .99).
Among the 17 survivors, 16 remained free from
dissection-related events during a mean follow-up of
38  23 months (range, 9-80 months), and 1 was lost to
follow-up. The stent graft in the 23 SINE patients had
been placed across the aortic arch. Among the 651
patients, 613 had across-arch endograft placement,
whereas in 38, the endoprosthesis was fixed at the
straight segment of the descending thoracic aorta. The
incidence of SINE was not significantly different be-
tween these two groups (23 of 613 vs 0 of 38; P  .39).
In patient 3, asymptomatic distal SINE was revealed on
follow-up CTA 28 months after the primary TEVAR. He
presented with chest pain and fever 1month later, and CTA
demonstrated the proximal SINE and resultant RTAD. He
underwent an emergency graft replacement of the ascend-
ing thoracic aorta and partial arch. At 41 months, the distal
SINE expanded; however, the patient refused a secondary
TEVAR. Acute chest pain occurred at 56months, and CTA
evidenced the contained rupture at the level of the distal
SINE. A Hercules stent graft (40  38  120 mm) was
urgently implanted, and the follow-up CTA at 3 months
revealed satisfactory exclusion of the distal SINE, complete
thrombosis of false lumen, and pleural effusion absorption
(Fig 1).
In patient 23, the distal SINE was located at the level
between T7 and T8, so the stent graft was estimated to be
placed distally to the level of T10, raising the risk of spinal
cord ischemia. The Adamkiewicz artery, which was located
preoperatively by CTA at the level of T9, was unavoidably
sacrificed during the secondary TEVAR. CSF pressure in-
traoperatively was 12 cm H2O before deployment, in-
creased to 19 cm H2O directly after the stent graft was
released, and then decreased to 14 cm H2O after 8 mL of
CSF was drained. Monitoring was continued for 48 hours
after TEVAR and drainage was repeated twice, maintaining
the pressure between 9 and 13 cm H2O. The patient was
free of neurologic events perioperatively and during 3
months of follow-up.
DISCUSSION
A variety of devices have been designed for TEVAR
since the end of last century. The ability of the device to
self-expand is a common basic feature that might create
stress on the aortic wall in two manners. One is its radial
force that, to a large extent, depends on how much the
endograft had been oversized. The other is the “spring-
back” force, by which we mean that the endograft, like a
spring, has an inherent tendency to spring back to its
initial straight status when passively bent at the aortic
arch, thus generating stress on the greater curve, espe-
cially at its two ends (Fig 1). This situation exists in most
JOURNAL OF VASCULAR SURGERY
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quently occurs adjacent to the aortic isthmus, necessitat-
ing the across-arch placement of the endograft, which
was seen in 613 (including 23 SINEs) of the 651 patients
in our center.
Even though the statistical analysis failed to show a
significant difference in incidence of SINE between across-
arch placement (3.8%, 23 of 613) and placement at a
straight aortic segment (0 of 38), possibly because of the
relatively small number of the patients in the latter group
and the low incidence of SINE, the spring-back force was
considered an important factor in the stent graft-induced
injury, given that no SINE was observed in the group that
did not undergo across-arch placement and the common
feature of the “spring” to spontaneously turn back to
straight if passively curved. It could also be estimated that
the more the endograft is bent, the higher the stress might
be, and that the stress would be stronger at the end closer to
the curving point of the endograft than at the other end
(Fig 2).
As for the formation of the proximal SINE, the stress
from the spring-back force would contribute more than
Fig 2. A, The stent graft is frequently placed across th
end (dot a) of the endograft (green shade) is usually mu
c); that is to say that segment ab is shorter than segmen
proximal tip and causing the proximal stent graft-ind
proximal SINE developed 1 week after thoracic end
conversion, it was evidenced that the proximal bare spr
lumen. D, Twelve months after the David procedure
raphy showed a stable arch and expanded distal true lu
entry would probably develop at the distal end. F, As o
after TEVAR. G, The angiogram during the secondar
additional stent graft was implanted with distal overlap
the distribution of the stress and transfer its concentra
possibly causing the subsequent proximal SINE and r
to be responsible for his sudden death 1 month later.that from the radial force because:1. All proximal SINE tears occurred at the greater curve,
consistent with the route of the spring-back movement
of the endograft.
2. Typically, the proximal end of the endograft is much
closer to the curving point than the distal one, thus
probably making the stress more concentrated on the
proximal tip (Fig 2).
3. Even though the radial force was minimized through a
very limited oversizing, such as only 3% in patient 13,
proximal SINE still developed. Also, there was no sig-
nificant difference in the oversizing rate between the
SINE group and non-SINE group.
4. The injury by the strong radial force of the proximal bare
spring has always been regarded as the predominant
cause for proximal SINE.
Nevertheless, proximal SINE had also been ob-
served in patients treated with the device without the
bare spring.18,23,24,36 In particular, a large-sample study
reported in 2008 by Kpodonu et al24 showed that
RTAD developed in 7 of 287 cases of TEVAR using the
Gore TAG thoracic endoprosthesis (W. L. Gore and
tic arch in type B dissection patients, and the proximal
ser to the curving point (dot b) than the distal one (dot
probably making the stress more concentrated on its
new entry (SINE). B, As occurred in patient 13, the
ular aortic repair (TEVAR). C, During the surgical
rrow) created a new entry and protruded into the false
emiarch replacement, computed tomography angiog-
E, If segment ab were longer than segment bc, the new
ed in patient 19, the distal SINE occurred 15 months
VAR clearly revealed the distal SINE (arrow). H, An
with the original one, which, however, might change
from the distal to the proximal end of the endograft,
nt retrograde type A dissection, which was suspectede aor
ch clo
t bc,
uced
ovasc
ing (a
and s
men.
ccurr
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ping
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esultaAssociates, Flagstaff, Ariz) without the bare spring, with
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(11 of 443) we reported with the Talent device.25
In the seven cases of distal SINE, it is interesting that
the new entry had been evidenced on the dissected flap at
the either lesser or greater curve, unlike the proximal SINE
tears, which were all at the greater curve. The stent graft
was routinely oversized according to the proximal landing
zone, which was typically much larger than the distal true
lumen which thus had to endure a relatively higher radial
force than the proximal segment (Fig 3). Moreover, the
dissected flap was far more fragile than the uninvolved
aortic wall and hence more subject to being injured. There-
fore, the stress from the radial force was deemed predomi-
nantly responsible for the occurrence of the distal SINE. Xu
et al37 studied the difference in diameter between the aortic
arch and the distal true lumen at the descending thoracic
aorta in patients with type B dissection. The taper ratio,
defined as [(arch diameter – distal true lumen diameter)/
Fig 3. A to D, Preoperative computed tomography an
aortic diameter of 50 mm and the evident gap of diamet
true lumen (10 mm), at which level there was no entry th
endovascular aortic repair with ZTEG-2P (34 15, Zen
false lumen, expansion of the distal true lumen up to 20 m
fixed. I to L, CTA at 3 months showed that the maximu
lumen significantly expanded up to 36 mm, and that a
arrow). The new false lumen was noted to be independen
months evidenced that the maximum aortic diameter fu
caused aortic enlargement from 36 to 40 mm.arch diameter], was significantly larger in acute and chronicdissection patients than in healthy people. The authors
noted that oversizing according to the aortic arch meant
excessive oversizing for the distal true lumen and poten-
tially causing rupture of the already dissected membrane.37
Another aspect to be considered in assessment of the
risk for SINE is the pathologic fragility of aortic wall.
Marfan syndrome was well recognized for its effect on
aortic wall weakness and a notable tendency to progres-
sively involve the residual aorta after surgical or endovascu-
lar treatment for the primarily affected aortic segment.38,39
The significantly higher incidence of SINE among Marfan
patients in this series suggested a Marfan predisposition to
this complication and implicated the fragility of the aortic
wall would increase the risk for SINE. However, only a
small number ofMarfan patients were treated in the current
survey, and a further investigation with a larger sample is
needed to establish association between Marfan and SINE.
Given the substantial mortality of SINE, it would be
aphy (CTA) in patient 17 demonstrated the maximum
tween the proximal landing area (30 mm) and the distal
. E to H, The patient had chest pain 1 day after thoracic
2, Cook). CTA revealed a remarkable thrombosis of the
nd still no entry at that level where the stent graft distally
rtic diameter had shrunk to 45 mm, that the distal true
l stent graft-induced new entry (SINE) occurred (short
he original false lumen (long arrow).M to P, CTA at 12
decreased to 40 mm, and the distal SINE (arrow) hadgiogr
er be
us far
ith TX
m, a
m ao
dista
t of t
rthermeaningful to take measures to minimize its occurrence.
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the endograft could be placed more proximally to avoid
angulation with the arch, even if the requisite minimal
landing distance of 15 mm is already achieved. In addi-
tion, avoid placing the proximal bare stent into the
origin of the three main branches of the aortic arch in
case it might penetrate the arterial wall and create a new
entry. For the distal landing, anchoring at a tortuous
portion should be avoided by careful preoperative mea-
suring and selecting an endograft with the appropriate
length (Fig 4).
Second, the design of the device is pending improve-
ment for dissection. A MEDLINE search found that much
fewer post-TEVAR new entries were developing in aneu-
rysm cases (n  6)13,17,21,24,35 than in dissection patients
(n 64).3-22,24,30-34 Similarly, no SINEwas observed after
TEVAR in the 39 patients with thoracic aortic aneurysms in
our center to date, implicating the probability that a dissec-
tion was more prone to development of SINE than an
Fig 4. More attention needs to be given to an optimal
fixation distance.A, From the standpoint of theminimal r
have been enough to place the endograft right proximal
it would achieve better compliance if the endoprosthes
artery (red line). B, So we ultimately fixed the endograft p
Otherwise, as in this case, the proximal end of the stent
greater curve (arrow) increasing the risk of wall injury
protruding into either origin of the three main branches.
common carotid artery, and its tip was almost perpendi
increasing the risk of injury. E to G, In patient 21,
demonstrated satisfactory proximal false lumen thrombo
stent graft with the descending thoracic aorta and the d
SINE was located at the dissected flap and did not comm
CTA at 12 months revealed complete false lumen thromb
stopped at the tortuous segment of the descending thora
the dissected flap and independent of the primary false lu
a longer endograft that could extendmore distally down t
compliance.aneurysm. Most commercial devices currently availablehave been designed for thoracic atherosclerotic aneurysms
with strong radial force, and the diameter of both ends is
usually identical or just had 2-mm tapering. In contrast, a
dissection-specific device calls for lower radial force, higher
flexibility, andmore tapering of the distal segment. Besides,
the diameter of the distal true lumen would be added into
the preoperative sizing, and a tapered device might be
conducive if the distal true lumen is far smaller than the
proximal landing zone.
Third, it would be best if the graft manufacturer
could provide some mechanical indexes of the endograft,
such as the radial force and the spring-back force when
passively curved at a given angle. In this way, physicians
can select a more appropriate device for each individual
patient, particularly those with difficult anatomy or spe-
cific etiology.
Fourth, we currently try to avoid stent grafting in
Marfan patients, but if one is to be used in patients with
Marfan syndrome or a kinked aortic arch, we prefer the
liance of the stent graft with the aorta in addition to its
ement of the 15-mmproximal landing distance, it would
e left subclavian artery (blue line) in this case. However,
ld be deployed immediately distal to the left common
ally at the red line, achieving an optimal compliance.C,
t would probably spring up and be angulated, with the
The proximal bare spring needs to be prevented from
as in this case, the proximal bare spring went into the left
y pointed against the arterial wall (arrow), substantially
uted tomography angiography (CTA) at 33 months
t unsatisfactory compliance of the distal portion of the
tent graft-induced new entry (SINE; arrow). The distal
ate with the original false lumen. H to J, In patient 20,
t the proximal segment. However, the endograft distally
rta and created a distal SINE (arrow), which was also at
. It would have been better in patients 21 and 20 to use
relatively straight portion of the aorta and acquire bettercomp
equir
to th
is cou
roxim
graf
. D,
Such
cularl
comp
sis bu
istal s
unic
osis a
cic ao
men
o thedevice without the proximal bare spring.
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SINE appeared to be an infrequent but high-mortality
complication after TEVAR for type B dissection. The
stress-induced injury from the endograft seems to make
predominant contributions to its development. If we could
treat patients with TEVAR not only in a mechanical fashion
but also from the perspective of biomechanics, SINEmight
be lessened and the minimally invasive TEVAR would be
more minimally invasive.
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